Centre Hospitalier Universitaire
Dijon, 21079, France
NCT Number: NCT02824107
The aim of this study is to identify groups of subjects at risk of recurrence in secondary prevention based on Psychosocial Factors.
The aim is also to propose novel levers to reduce health inequalities in this population so as to develop new prevention strategies for neuro- and cardio-vascular health This study is based on data from questionnaires (Quality of life at work, perceived stress, perceived disease severity) and on behavior indicators (factors related to lifestyle: alcohol, smoking, obesity, sedentarity).
Biomarkers of endothelial function (ADMA) will also be assayed. It's an interventional study because of blood sample
Looking for future studies?
Notify MeUp to 65 year
All sexes
Interventional
Not applicable
Dijon, 21079, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: through the completion study an average of 6 month
Time frame: 1st day
Centre Hospitalier Universitaire Dijon
Other
INEqualities in Health Psychosocial Determinants of Neuro and Cardio-V@scuLar Disease: Identification of Novel Levers for Secondary Prevention
Acronym: INEV@L
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02425345
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT05820295
Arrhythmias, Cardiac, Atrial Fibrillation
New York, United States
View Trial DetailsNCT03419325
Acute Coronary Syndrome, Arterial Occlusive Diseases
Carolina, Puerto Rico
View Trial DetailsNCT02819791
Brain Diseases, Cardiovascular Diseases
Pessac, France
View Trial Details